Technical Analysis for ATNM - Actinium Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New Uptrend | Bullish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
200 DMA Support | Bullish | -3.11% | |
Bullish Engulfing | Bullish | -3.11% | |
Pocket Pivot | Bullish Swing Setup | -3.11% | |
Wide Bands | Range Expansion | -3.11% | |
Oversold Stochastic | Weakness | -3.11% | |
New Downtrend | Bearish | 4.31% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 18 hours ago |
Down 5% | about 18 hours ago |
Down 3% | about 18 hours ago |
Down 2 % | about 18 hours ago |
Down 1% | about 19 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 11/14/2023
Actinium Pharmaceuticals, Inc. Description
Actinium Pharmaceuticals, Inc., formerly Cactus Ventures, Inc. is a biopharmaceutical company developing cancer drugs. The Company's advanced products are Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), in human clinical trials for acute myeloid leukemia (AML) and Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. In addition, the Ac-225 based drugs development relies on the patented Alpha Particle Immunotherapy Technology (APIT) platform technology co-developed with Memorial Sloan- Kettering Cancer Center (MSKCC), a related institution. The APIT technology couples monoclonal antibodies (mAb) with extremely potent but comparatively safe alpha particle emitting radioactive isotopes, in particular actinium 225 and bismuth 213.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immunology Natural Sciences Immunotherapy Antibodies Chemical Elements Monoclonal Antibodies Stem Cell Monoclonal Antibody Acute Myeloid Leukemia Platform Technology Transplantation Hematopoietic Stem Cell Cancer Center Actinides Iodine Bismuth Immunotherapy Technology Kettering Cancer Center Memorial Sloan
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 9.55 |
52 Week Low | 4.0 |
Average Volume | 197,493 |
200-Day Moving Average | 6.18 |
50-Day Moving Average | 6.17 |
20-Day Moving Average | 7.38 |
10-Day Moving Average | 7.06 |
Average True Range | 0.53 |
RSI (14) | 46.24 |
ADX | 32.03 |
+DI | 22.57 |
-DI | 22.08 |
Chandelier Exit (Long, 3 ATRs) | 7.20 |
Chandelier Exit (Short, 3 ATRs) | 7.19 |
Upper Bollinger Bands | 8.84 |
Lower Bollinger Band | 5.91 |
Percent B (%b) | 0.21 |
BandWidth | 39.75 |
MACD Line | 0.12 |
MACD Signal Line | 0.35 |
MACD Histogram | -0.2276 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 7.49 | ||||
Resistance 3 (R3) | 7.53 | 7.25 | 7.33 | ||
Resistance 2 (R2) | 7.25 | 7.01 | 7.23 | 7.27 | |
Resistance 1 (R1) | 6.90 | 6.86 | 6.76 | 6.86 | 7.22 |
Pivot Point | 6.62 | 6.62 | 6.56 | 6.60 | 6.62 |
Support 1 (S1) | 6.27 | 6.38 | 6.13 | 6.23 | 5.86 |
Support 2 (S2) | 5.99 | 6.23 | 5.97 | 5.81 | |
Support 3 (S3) | 5.64 | 5.99 | 5.75 | ||
Support 4 (S4) | 5.60 |